Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> MULTIPLE SCLEROSIS Latest News

FEB 06, 2013 - Yahoo! News

A Must Read - Share

Biogen's purchase of MS drug ends rocky partnership with Elan

BOSTON (Reuters) - Biogen Idec Inc's agreement to buy Elan Corp Plc's interest in the multiple sclerosis drug Tysabri gives Biogen full control of a product that is poised for further growth and ends a long partnership that has often been contentious. Analysts have speculated for several years that Biogen could acquire Elan to take control of Tysabri. The current agreement, under which Biogen will pay Elan $3.25 billion in cash plus royalties, gives Biogen the asset it is most interested in while leaving Elan with money to spend on acquisitions and to develop its pipeline of experimental ...

Tags: Biogen's purchase of MS drug ends rocky partnership with Elan,  Multiple Sclerosis Latest News